- Home
- YHGJ vs CRIS Comparison
YHGJ vs CRIS Comparison
Compare YHGJ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- CRIS
- Stock Information
- Founded
- YHGJ 1975
- CRIS 2000
- Country
- YHGJ United States
- CRIS United States
- Employees
- YHGJ N/A
- CRIS N/A
- Industry
- YHGJ Specialty Chemicals
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YHGJ Industrials
- CRIS Health Care
- Exchange
- YHGJ Nasdaq
- CRIS Nasdaq
- Market Cap
- YHGJ 13.9M
- CRIS 14.6M
- IPO Year
- YHGJ 1997
- CRIS 2000
- Fundamental
- Price
- YHGJ $4.88
- CRIS $1.25
- Analyst Decision
- YHGJ
- CRIS Strong Buy
- Analyst Count
- YHGJ 0
- CRIS 2
- Target Price
- YHGJ N/A
- CRIS $16.50
- AVG Volume (30 Days)
- YHGJ 6.3K
- CRIS 96.5K
- Earning Date
- YHGJ 11-13-2025
- CRIS 11-06-2025
- Dividend Yield
- YHGJ N/A
- CRIS N/A
- EPS Growth
- YHGJ N/A
- CRIS N/A
- EPS
- YHGJ N/A
- CRIS N/A
- Revenue
- YHGJ $19,377,000.00
- CRIS $11,650,000.00
- Revenue This Year
- YHGJ N/A
- CRIS $2.72
- Revenue Next Year
- YHGJ N/A
- CRIS $8.27
- P/E Ratio
- YHGJ N/A
- CRIS N/A
- Revenue Growth
- YHGJ 4.41
- CRIS 13.56
- 52 Week Low
- YHGJ $4.35
- CRIS $1.02
- 52 Week High
- YHGJ $12.70
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- YHGJ 48.39
- CRIS 47.93
- Support Level
- YHGJ $4.83
- CRIS $1.08
- Resistance Level
- YHGJ $5.60
- CRIS $1.21
- Average True Range (ATR)
- YHGJ 0.26
- CRIS 0.13
- MACD
- YHGJ -0.10
- CRIS 0.00
- Stochastic Oscillator
- YHGJ 8.38
- CRIS 74.16
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.